AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dare Bioscience, Inc. Director's Dealing 2019

Apr 15, 2019

34825_dirs_2019-04-15_67ba8eb4-1d9b-4c2d-9b4c-46f3717ef04c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2019-04-11

Reporting Person: HAWLEY ROGER (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-11	Common stock	P	454545	$1.10	Acquired	944956	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	140000	Direct

Footnotes

F1: The reported securities were purchased by the reporting person in the underwritten public offering of the issuer which closed on April 11, 2019. The reported securities are held in The Hawley Family Trust Dated October 22, 2004, of which the reporting person is the trustee.